These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36636093)

  • 1. Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer.
    Luo HY; Tang WL; Xiang L; Peng LL; Wu DB; Zhu ZY; Gu HT; Tang YH; Perkins RS; Shen HY; Wang YX
    J Gastrointest Oncol; 2022 Dec; 13(6):3025-3037. PubMed ID: 36636093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
    Zhang C; Zhao Z; Liu H; Yao S; Zhao D
    Front Genet; 2021; 12():657658. PubMed ID: 34322151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
    Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
    Front Genet; 2022; 13():821826. PubMed ID: 35664320
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
    Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
    Front Oncol; 2021; 11():633420. PubMed ID: 33747955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma.
    Ai F; Wang W; Liu S; Zhang D; Yang Z; Liu F
    Front Oncol; 2022; 12():871568. PubMed ID: 35847888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma.
    Lin J; Luo B; Yu X; Yang Z; Wang M; Cai W
    Front Oncol; 2022; 12():959273. PubMed ID: 36203457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.
    Liu L; Liang L; Mai G; Chen Y
    FASEB Bioadv; 2022 Sep; 4(9):585-601. PubMed ID: 36089979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD).
    Wang L; Cao Y; Guo W; Xu J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):15-24. PubMed ID: 36173462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
    Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
    Front Genet; 2023; 14():1098190. PubMed ID: 37274780
    [No Abstract]   [Full Text] [Related]  

  • 19. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
    Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
    Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma.
    Yang W; Luo C; Chen S
    Front Genet; 2022; 13():986325. PubMed ID: 36506326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.